The use of herbal medications and dietary supplements by people with mental illness.
This study examined the relationship between herbal medication and dietary supplement (HMDS) use and mental health characteristics. Data are drawn from a national household survey of the United States' civilian, non-institutionalized population (N = 9,585). Psychiatric medication and HMDS use, psychiatric diagnoses and treatment needs, utilization and satisfaction were assessed. Compared to non-users, HMDS users were more likely to perceive themselves as having mental health needs, to have received mental health and primary care treatment, and to be dissatisfied with their overall healthcare. Psychiatric medication use was not related to HMDS use, and in multivariate analyses, HMDS use was associated with perceived mental health needs. Differences in use of specific HMDS between those with and without a psychiatric disorder were also examined. The use of HMDS warrants particular attention in persons with perceived mental health problems as these individuals may be turning to HMDS use for treatment of their symptoms.
Niv
Noosha
N
Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center, Los Angeles, CA, USA. noosha23@yahoo.com
Shatkin
Jess P
JP
Hamilton
Alison B
AB
Unützer
Jürgen
J
Klap
Ruth
R
Young
Alexander S
AS
D000328:Adult; D000368:Aged; D003625:Data Collection; D019587:Dietary Supplements / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D008603:Mental Health; D008605:Mental Health Services / Q000706:statistics & numerical data; D008875:Middle Aged; D015999:Multivariate Analysis; D010342:Patient Acceptance of Health Care; D008517:Phytotherapy / Q000706:statistics & numerical data*; D028321:Plant Preparations; D015995:Prevalence; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012959:Socioeconomic Factors; D014481:United States / Q000453:epidemiology
D028321:Plant Preparations; D011619:Psychotropic Drugs
Med Care. 1996 Mar;34(3):220-33
8628042
J Psychiatry Neurosci. 2000 Jan;25(1):48-52
10721684
Am J Psychiatry. 2000 Nov;157(11):1851-7
11058485
Psychiatr Serv. 1998 Nov;49(11):1397
9826237
Psychol Rep. 2005 Feb;96(1):163-6
15825920
JAMA. 1999 Aug 18;282(7):651-6
10517718
Arch Gen Psychiatry. 2001 Jan;58(1):55-61
11146758
JAMA. 1998 May 20;279(19):1548-53
9605899
Arch Intern Med. 2000 Jan 24;160(2):152-6
10647752
Arch Gen Psychiatry. 2000 Jul;57(7):708-14
10891042
J Nerv Ment Dis. 1999 Sep;187(9):532-8
10496508
Med Care. 1993 Mar;31(3):189-200
8450677
Am J Psychiatry. 2001 Feb;158(2):289-94
11156813
Inquiry. 1999 Summer;36(2):221-33
10459376
Gen Hosp Psychiatry. 2003 Jan-Feb;25(1):24-6
12583924
Psychiatr Q. 2002 Winter;73(4):367-81
12418362
Adv Data. 2004 May 27;(343):1-19
15188733
CNS Spectr. 2001 Oct;6(10):827-32
15334037
Psychol Med. 2007 Jan;37(1):73-84
16999879
JAMA. 2002 Jan 16;287(3):337-44
11790213
JAMA. 2002 Apr 10;287(14):1807-14
11939866
Psychiatry Res. 2004 Dec 30;129(3):297-301
15661325
Psychosomatics. 2005 Mar-Apr;46(2):117-22
15774949
Br J Psychiatry. 2005 Feb;186:99-107
15684231
Arch Intern Med. 2005 Feb 14;165(3):281-6
15710790
JAMA. 1998 Nov 11;280(18):1569-75
9820257
Br J Psychiatry. 2006 Feb;188:109-21
16449696
J Nerv Ment Dis. 1999 Nov;187(11):692-5
10579598
Med Hypotheses. 2005;65(5):823-8
16111835
Psychiatry Res. 1998 Jan 16;77(1):57-61
10710176
Am J Psychiatry. 1999 Sep;156(9):1432-8
10484957
Inquiry. 1996 Summer;33(2):195-206
8675282
J Altern Complement Med. 2006 Jun;12(5):467-73
16813511
J Clin Psychiatry. 2000 May;61(5):373-7
10847313